Skip navigation

Align Global Data Collection and Analysis Systems • Ensure Cross Functional Collaboration and Preparedness • Achieve Accurate and Timely Reporting

November 7, 2018
  • Philadelphia, PA

Being adequately prepared for pharmacovigilance audits and inspections is crucial to any bio/pharma company committed to maintaining the highest standards for safety and risk management.

CBI’s Pharmacovigilance Audits and Inspections Summit provides insights on the most pressing issues and challenges related to managing the growing volume and frequency of audits and inspections. This event has been specifically designed to provide timely and detailed guidance to busy PV attendees in a single day. It examines complex subjects such as facilitating cross departmental PV engagement, identifying best practices for working with inspectors, developing and implementing effective PV agreements, handling large scale data sets (including social media signal data), developing comprehensive reports using automation tools and tracking evolving global regulations (with a focus on detailed European requirements).

Organizations that want to reach a continual state of PV audit and inspection readiness can’t afford to miss this chance to benchmark and learn from both colleagues and vendors that have successfully navigated these pathways.

Top Reasons to Attend:

  • Participate in interactive “How To” sessions on how to improve your audit and inspection management processes
  • Examine forthcoming global and domestic regulatory changes
  • Benefit from discussions featuring experienced pharmacovigilance specialists sharing real life lessons learned on inspections and best practices
  • Navigate the murky waters of data management to optimize reporting, monitoring and validation methods
  • Explore and benchmark with peers on ways to develop stronger automation programs